BTK inhibitors: toxicity, resistance, and combinations
Steven T. Rosen, MD, from the City of Hope, Duarte, CA, discusses recent developments in BTK inhibitors at the 2017 International Workshop in Non-Hodgkin Lymphoma (iwNHL) in Vancouver, BC, Canada. BTK...
Author: VJHemOnc
Added: 11/21/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 21, 2017 Category: Cancer & Oncology Source Type: podcasts
Exciting advances in checkpoint inhibitors CAR T-cells, and ALK inhibitors
Steven T. Rosen, MD, from the City of Hope, Duarte, CA, discusses highlights of the 2017 International Workshop in Non-Hodgkin Lymphoma (iwNHL) in Vancouver, BC, Canada. More concrete data had been re...
Author: VJHemOnc
Added: 11/20/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 20, 2017 Category: Cancer & Oncology Source Type: podcasts
Side effects of novel PI3K inhibitors
Nathan Fowler, MD, from the University of Texas MD Anderson Cancer Center, Houston, TX, discusses side effects of PI3K inhibitors at the 2017 International Workshop in Non-Hodgkin Lymphoma (iwNHL) in ...
Author: VJHemOnc
Added: 11/17/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 17, 2017 Category: Cancer & Oncology Source Type: podcasts
iwNHL 2017 highlights: the PDX model
Marek Trneny, MD, from the Charles University, Prague, Czech Republic, discusses highlights from the International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2017, held in Vancouver, BC, Canada. The PDX...
Author: VJHemOnc
Added: 11/17/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 17, 2017 Category: Cancer & Oncology Source Type: podcasts
CC122: a new IMiD in the treatment of diffuse large B-cell lymphoma
John Kuruvilla, MD, FRCPC, from the Princess Margaret Cancer Centre, Toronto, Canada, discusses the development of IMiDs at the International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2017, held in Van...
Author: VJHemOnc
Added: 11/17/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 17, 2017 Category: Cancer & Oncology Source Type: podcasts
Targeting chemokines in lymphoma
Francine Foss, MD, from the Yale University School of Medicine, New Haven, CT, discusses targeting chemokines at the International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2017 meeting, held in Vancou...
Author: VJHemOnc
Added: 11/16/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 16, 2017 Category: Cancer & Oncology Source Type: podcasts
Do CAR T-Cell therapies look promising for the treatment of NHL?
Jeff Sharman, MD of Willamette Valley Cancer Center discusses whether or not CAR T-cell therapy is promising for the treatment of non-hodgkin lymphoma. This was recorded at the 2017 ASCO Annual Meetin...
Author: obr
Added: 06/22/2017 (Source: Oncology Tube)
Source: Oncology Tube - June 22, 2017 Category: Cancer & Oncology Source Type: podcasts
Results of the MAGNIFY study for high-risk indolent non-hodgkin lymphoma patients
Kathryn Kolibaba, MD of US Oncology Research discusses the MAGNIFY study and its impact on high-risk indolent NHL patients at the 2017 ASCO Annual Meeting in Chicago, IL.
Author: obr
Added: 06/21/2017 (Source: Oncology Tube)
Source: Oncology Tube - June 21, 2017 Category: Cancer & Oncology Source Type: podcasts
Results of BRIGHT study in front line indolent non-hodgkin lymphoma patients
Kathryn Kolibaba, MD of US Oncology Research gives an overview of the results from the BRIGHT study and its impact on treatment for indolent non-hodgkin lymphoma patients. This was recorded at the 201...
Author: obr
Added: 06/21/2017 (Source: Oncology Tube)
Source: Oncology Tube - June 21, 2017 Category: Cancer & Oncology Source Type: podcasts
Keeping Family in Mind: A Cancer Survivors Advice for Experts
As part of our coverage of the 2017 ASCO Survivorship Symposium, non-Hodgkin lymphoma survivor, Lou Lanza, talks about his hope for the future and advice he shared with his medical team.<br /><br />Get email ...
Author: patientpower
Added: 02/22/2017 (Source: Oncology Tube)
Source: Oncology Tube - February 23, 2017 Category: Cancer & Oncology Source Type: podcasts
Update on Antibody Therapies in Indolent Non-Hodgkin Lymphoma
GRACE is pleased to present a series of webcasts with faculty member John Pagel, MD, PhD, DSc, from Swedish Cancer Institute. Dr. Pagel was one of many to attend the American Society of Hematologys A...
Author: cancergrace
Added: 01/17/2017 (Source: Oncology Tube)
Source: Oncology Tube - January 17, 2017 Category: Cancer & Oncology Source Type: podcasts
